ARCHIVES

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Lymphoma Research Foundation names William Hawley president.

January 23, 2004

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976

In Brief: ASCO awards career development grants.

May 21, 2004

Program Project Guidelines Listed

March 18, 1977

Breast Cancer Treatment Studies Need Standard Definitions – Carbone

May 10, 1974

CAP, ASCCP Recommendations Standardize Lesion Terminology

July 27, 2012